Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This may lead to an inhibition of both cell proliferation and survival in MELK-expressing tumor cells
a ligand of FGFR1 and FGFR4
InChiKey: LCPFHXWLJMNKNC-PFEQFJNWSA-N
InChi: InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6
GW-3965 HCl
MDA 19 Size:Solid 10 mg This may lead to anMDA19 or MDA 19 is discontinued (DEA controlled substance). It is a selective agonist of the human peripheral cannabinoid (CB2) receptor, with an EC50 value for activation (63. 4 nM) that is 14 fold lower than that for central cannabinoid (CB1) activation (EC50 = 867 nM). MDA19 exhibited a distinctive in vitro functional profile at rat CB2 receptors and behaved as a CB1 CB2 agonist in vivo, characteristics of a protean agonist. MDA19 has potential for